机器人辅助手术治疗儿童肿瘤:单中心114例研究
该单中心回顾性研究分析了2021年6月至2024年1月在北京儿童医院接受机器人辅助手术的114例儿童肿瘤患者,其中神经母细胞瘤占42.98%、生殖细胞肿瘤占28.95%。无术中肿瘤破裂发生,中位住院6天,术后并发症率2.63%,结论认为机器人辅助手术对选定儿童肿瘤安全可行。
要点
- 儿童肿瘤机器人辅助手术术后并发症率2.63%,无术中肿瘤破裂。
- 神经母细胞瘤和生殖细胞肿瘤是最常见的手术病种。
- 中位住院时间6天,体现术后恢复较快。
核心结论
- 机器人辅助手术对儿童肿瘤是安全可行的,可减少手术创伤并加快术后恢复。
- 在具备充分手术技术条件下,机器人辅助手术可获得与开放手术相当的肿瘤学结局,是选定儿童患者的 promising 替代方案。
研究设计与样本
- 回顾性分析2021年6月至2024年1月北京儿童医院肿瘤外科接受机器人辅助手术的儿童患者。
- 共纳入114例儿童(女64例),其中2例同期接受机器人辅助胸腔镜和腹腔镜手术。
主要发现
- 神经母细胞瘤49例(42.98%)最多,其次为生殖细胞肿瘤33例(28.95%)。
- 其余32例肿瘤包括胰腺2例、肾脏2例(肾透明细胞肉瘤1例、肾癌1例)、肝母细胞瘤3例、肝细胞癌1例及其他罕见肿瘤24例。
- 无术中肿瘤破裂发生;2例4S期神经母细胞瘤患儿同期行肝转移灶活检。
- 中位住院时间6天(4-7天),术后并发症率2.63%。
临床怎么用
- 对于选定的儿童肿瘤患者,可考虑机器人辅助手术作为一种减少创伤、加快恢复的术式选择。
- 实施机器人辅助手术需具备充分的儿童肿瘤手术技术条件,以保证肿瘤学结局。
局限性
- 本研究为单中心回顾性分析,证据等级有限。
- 原文未报告与开放手术的对照比较数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although robot-assisted surgery has been widely adopted for adult malignancies, its application in pediatric oncology remains contentious because of limited evidence. This study aims to assess the safety, feasibility, and surgical indications of robot-assisted surgery in pediatric oncology. METHOD: A retrospective analysis was conducted on pediatric patients who underwent robot-assisted surgery at the Department of Surgical Oncology, Beijing Children's Hospital, between June 2021 and January 2024. RESULTS: Overall, 114 children (64 female) were treated with robot-assisted surgery, including 2 children who underwent both robot-assisted thoracoscopic surgery and laparoscopic surgery at the same time. Of these, neuroblastic tumors (49, 42.98%) account for the most, followed by the germ cell tumor (33, 28.95%). The remaining 32 tumors included pancreatic (n = 2), renal (n = 2; 1 case of renal clear cell sarcoma, 1 case of renal carcinoma), hepatoblastoma (n = 3), hepatocellular carcinoma (n = 1), and other different rare tumors (n = 24). No intraoperative tumor rupture occurred. Additionally, 2 children with stage 4S neuroblastoma underwent concurrent biopsy of liver metastases. The median hospital stay was 6 days (4-7), and the postoperative complication rate was 2.63%. CONCLUSION: Robot-assisted surgery is a safe and feasible approach for pediatric tumors, offering reduced surgical trauma and faster postoperative recovery. With adequate surgical expertise, robot-assisted surgery can achieve oncologic outcomes comparable to open surgery, making it a promising alternative for selected pediatric patients.
引用
- Chang S, Feng J, Cheng Y, et al. Robot-assisted surgery for pediatric tumors: A single-center study of 114 cases. Surgery. 2025. PMID: 40850245. doi:10.1016/j.surg.2025.109616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。